Last $14.57 USD
Change Today +0.25 / 1.75%
Volume 242.9K
IRWD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph C. Cook Jr.

Co-Founder, Director and Member of Audit Committee, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 119 board members in 6 different organizations across 5 different industries.

See Board Relationships
72--

Background*

Mr. Joseph C. Cook, Jr., also known as Joe, is the Co-Founder and Principal of Mountain Group Capital LLC. Mr. Cook serves as President of NuSirt Sciences, Inc. He serves as the President of Cambrian Associates LLC. Mr. Cook has been Principal of Life Science Advisors, LLC since 1995 and has also been Principal of Cambrian Associates, LLC since 1994. He serves as an Officer of Mountain Ventures Inc., a Member of Life Science Advisors LLC, North American Biologicals Inc. ...

Read Full Background

Corporate Headquarters*

301 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-621-7722
Fax: 617-494-0480

Board Members Memberships*

Co-Founder, Director and Member of Audit Committee
Director
Director
Executive Chairman of The Board and President
1994-N/A
Former Chairman of the Board and Member of Finance Committee
1994-N/A
Director
1995-N/A
Former Director
2002-Present
Director, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee
2010-Present
Director

Education*

BSE 1965
University of Tennessee System, The

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options5,000
Total Number of Options5,000

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRWD:US $14.57 USD +0.25

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$515.4K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRONWOOD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.